OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of LMO7 in cancer (Review)
Qun Zeng, Tingting Jiang, Jing Wang
Oncology Reports (2024) Vol. 52, Iss. 3
Closed Access | Times Cited: 14

Showing 14 citing articles:

Spirulina-mediated biosynthesis of gold nanoparticles: an interdisciplinary study on antimicrobial, antioxidant, and anticancer properties
Mohammad Aamir, Said Hassan, Amir Hamza Khan, et al.
Journal of Sol-Gel Science and Technology (2025)
Closed Access

Spiroisatin pyranopyrimide derivatives as receptor tyrosine kinase inhibitors and targeted anticancer agents
Alireza Alipour, Paria Farhadi, Kourosh Mobaraki, et al.
Journal of Molecular Structure (2025), pp. 141576-141576
Closed Access

Transforming brain cancer biomarker research with patinformatics and SWOT analysis
Neha Saini, Amit Kumar Tiwari, Robert Leahy, et al.
Drug Discovery Today (2025), pp. 104314-104314
Open Access

MF59-based lipid nanocarriers for paclitaxel delivery: optimization and anticancer evaluation
Marzieh Attar, Fatemeh T. Shamsabadi, Alireza Soltani, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

Gadolinium (Gd)-based nanostructures as dual-armoured materials for microbial therapy and cancer theranostics
Nadhir N. A. Jafar, Junainah Abd Hamid, Farag M. A. Altalbawy, et al.
Journal of Microencapsulation (2025), pp. 1-27
Closed Access

Current Landscape and Future Directions in Cancer Immunotherapy: Therapies, Trials, and Challenges
S. A. Tilakaratne Bandara, Sreejith Raveendran
Cancers (2025) Vol. 17, Iss. 5, pp. 821-821
Open Access

Comprehensive pan-cancer analysis of LAMA3: implications for prognosis and immunotherapy
Hui Huang, Wei Dong, Xuan Qin, et al.
American Journal of Translational Research (2025) Vol. 17, Iss. 2, pp. 1200-1222
Closed Access

Functional mixed metal oxide nanomaterials: a comprehensive review of their hyperthermic potential in cancer therapy
Amol B. Pandhare, Swapnajit V. Mulik, Santosh S. Patil, et al.
New Journal of Chemistry (2025)
Closed Access

Tumor microenvironment: recent advances in understanding and its role in modulating cancer therapies
Disha D. Shah, Mehul R. Chorawala, Neha R. Raghani, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Closed Access

Non-coding RNAs (ncRNAs) as Therapeutic Targets and Biomarkers in Oligodendroglioma
Mohd Imran, Abdulmalik Saleh Alfawaz Altamimi, M. Arockia Babu, et al.
Pathology - Research and Practice (2024) Vol. 264, pp. 155708-155708
Closed Access

Emerging Innovations in Nanomedicine for Cancer Immunotherapy
Jaimin R. Shah, Devesh U. Kapoor, Bhupendra G. Prajapati
Journal of Drug Delivery Science and Technology (2024) Vol. 104, pp. 106584-106584
Closed Access

Page 1

Scroll to top